Patents by Inventor Jerk Vallgårda

Jerk Vallgårda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7618961
    Abstract: The present invention relates to compounds with the formula (II) and also to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: May 22, 2001
    Date of Patent: November 17, 2009
    Assignee: Biovitrum AB
    Inventors: Tjeerd Barf, Rikard Emond, Guido Kurz, Jerk Vallgårda, Marianne Nilsson
  • Patent number: 7125900
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: May 22, 2001
    Date of Patent: October 24, 2006
    Assignee: Biovitrum AB
    Inventors: Tjeerd Barf, Marianne Nilsson, Jerk Vallgårda, Guido Kurz
  • Patent number: 7094792
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: November 22, 2002
    Date of Patent: August 22, 2006
    Assignee: Biovitrum AB
    Inventors: Tjeerd Barf, Rikard Emond, Guido Kurz, Marianne Nilsson, Jerk Vallgårda, Lian Zhang
  • Patent number: 7074788
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: November 22, 2002
    Date of Patent: July 11, 2006
    Assignee: Biovitrum AB
    Inventors: Guido Kurz, Marianne Nilsson, Jerk Vallgårda, Meredith Williams
  • Patent number: 7030135
    Abstract: The present invention relates to using a compound having the formula (I) wherein T is I) thienyl, which optionally is substituted with halogen, or II) phenyl optionally substituted with halogen and/or C1-6-alkyl; E is a bond, —CH2— or —CO—; L is a bond, —CH2—, —CHR4— or —NR3—; R3 is H, C1-6-alkyl, C1-6-acyl or —COR4; R4 is morpholino or C1-6-amido; R6 and R7 are independently hydrogen or C1-6-alkyl; and R8 and R9 are independently hydrogen or C1-6-alkyl, as well as pharmaceutically acceptable salts, hydrates and solvates thereof, in the manufacture of a medicament for the treatment or prevention of diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia, depression, virus diseases and inflammatory disorders.
    Type: Grant
    Filed: May 22, 2001
    Date of Patent: April 18, 2006
    Assignee: Biovitrum AB
    Inventors: Marianne Nilsson, Jerk Vallgårda, Tjeerd Barf